ValueScreener

ValueScreener company report

Amrize Ltd (AMRZ)

NYSE / Basic Materials / Construction Materials

Share price

37.32 USD Market dataClose of Oct 15, 2026

Market capitalisation

20.41B USD Market dataClose of Oct 15, 2026
Market data
Oct 15, 2026
Filed accounts
FY2025, filed Feb 18, 2026
Ratios computed
Oct 15, 2026
Filed years
3, FY2023 to FY2025
Four kinds of sourceSEC filingCompany statementMarket dataComputedWhat each means
SEC filingFiled with the SEC
Read from a statement the company filed with the SEC, with the form, fiscal year, filing date and accession beside it.
Company statementCompany statement
What the company says about itself in a filing: an 8-K item, the auditor, its own segment names.
Market dataMarket data
Prices, market value and what analysts publish, with the date they are as of.
ComputedComputed by ValueScreener
Worked out by us from the other three, with the inputs and the formula one press away. A score is a research output, not a rating or a recommendation.
Reading

1 of 10

Overview

What the business is, what it costs, and how it reads on four questions.

Market dataSEC filingComputed

Four questions, at a glance

Quality

Return on invested capital, after tax

8.5% Computed

From the FY2025 filing

Read quality

Valuation

Price to earnings

17.44x Computed

FY2025 accounts, priced at the latest close

Read valuation

Cash generation

Free cash flow yield

6.9% Computed

FY2025 accounts, priced at the latest close

Read cash generation

Revenue and net income, by fiscal year

FY2021 Revenue: 8.13B USDFY2021 Net income: 841.0M USDFY2022 Revenue: 10.73B USDFY2022 Net income: 1.11B USDFY2023 Revenue: 11.68B USDFY2023 Net income: 956.0M USDFY2024 Revenue: 11.70B USDFY2024 Net income: 1.27B USDFY2025 Revenue: 11.81B USDFY2025 Net income: 1.19B USD
Revenue Net income5 fiscal years; a year whose statement names no SEC filing is market data, and the table in Filings says which.
Named tests met
0 of 30 Which tests
The business, and the score behind its five axes

The reading, in brief

Is it cheap

Price to earnings is 17.44x at the close of 2026-10-15 on FY2025 figures; the lines are 15.00x (Graham's defensive ceiling) and, by market convention, 10.00x, 25.00x and 40.00x, and this sits between 15.00x and 25.00x.

Today, against the Basic Materials sector (124 companies), 17.44x sits at the 36th percentile; the middle half of that group runs from 15.03x to 34.97x.

Is it good

Return on invested capital was 8.5% in FY2025, in the band labelled "Around the cost of capital" (8.0% to 12.0%), on lines anchored on Damodaran's cost-of-capital data.

Today, against the Basic Materials sector (99 companies), 8.5% sits at the 54th percentile; the middle half of that group runs from 1.5% to 12.9%.

Is it safe

Interest coverage was 4.13x in FY2025, in the band labelled "Investment grade" (3.00x to 6.00x), on lines anchored on Damodaran's interest-coverage table.

Year by year against peers
Whether Amrize Ltd's gross margin stayed above the median of the Basic Materials sector, year by year. (FY2021 to FY2025, 5 fiscal years of Amrize Ltd with a comparable figure)
The direction
Which way Amrize Ltd's gross margin has moved, and how steadily. (FY2021 to FY2025, 5 filed years of Amrize Ltd)
What could explain it
What in Amrize Ltd's filed statements could explain the movements. (8 readings drawn from the statement lines Amrize Ltd filed)
What to check next
What to check next on Amrize Ltd, and where in its filings. (4 questions for Amrize Ltd)
In one paragraph
One paragraph on Amrize Ltd's returns, cash, balance sheet and price. (14 of sixteen figures read for Amrize Ltd)

These are AMRZ’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.

Research AMRZPart of Serious. New accounts start with 30 days of Professional, free, no card.

2 of 10

What changed

The newest filing, what it moved, and when the next one is due.

SEC filingCompany statement

The newest accounts on file are the FY2025 annual report: 10-K, filed Feb 18, 2026, accession 0002035989-26-000017.

3 of 10

Quality

The returns the business earns on its capital, and the margins behind them.

SEC filingComputed

Amrize Ltd: returns on capital and margins, each with its source
FigureValue, source and document
Return on invested capital, after tax8.5% ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Return on equity9.0% ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Return on capital employed, pre-tax8.9% ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Return on assets4.9% ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Gross margin25.7% ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Operating margin16.1% ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Net margin10.0% ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
AMRZ 10.0%
JHX 2.1%CRH 10.0%CX 5.8%VMC 13.6%MLM 18.5%
2.1%18.5%
Net margin: AMRZ against the 5 companies named under Valuation context, each as filed for its own latest year. Placement only: no average is drawn.

4 of 10

Financial strength

What it owes against what it owns, and whether it can meet what falls due.

SEC filingComputedCompany statement

Amrize Ltd: leverage, liquidity and distress, each with its source
FigureValue, source and document
Debt to equity0.48 ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Current ratio1.60 ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Quick ratio1.08 ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Interest coverage4.13x ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Altman Z-score2.01 ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Net debt4.42B ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Total assets 24.21BTotal liabilities 11.09BShareholders' equity 13.13BOwnsOwes, and equity
Total assets Total liabilities Shareholders’ equity
The balance sheet, line by line

Financial health

What Amrize Ltd owned and owed at the end of fiscal 2025, from the balance sheet it filed (10-K, filed Feb 18, 2026, 0002035989-26-000017).

Amrize Ltd: balance sheet position
Total assets24.21B FiledFY2025 10-K, filed Feb 18, 2026
Total liabilities11.09B FiledFY2025 10-K, filed Feb 18, 2026
Shareholders' equity13.13B FiledFY2025 10-K, filed Feb 18, 2026
Cash1.92B FiledFY2025 10-K, filed Feb 18, 2026
Total debt6.34B FiledFY2025 10-K, filed Feb 18, 2026
Net debt4.42B
Current ratio1.60
Debt to equity0.48

Read from the filed balance sheet for each year, with the income statement of the same year supplying operating profit where a ratio needs it. Nothing here is a view on whether this company is sound.

5 of 10

Valuation context

What the market charges for it, against its own record and companies like it.

Market dataSEC filingComputed

Amrize Ltd: what the market charges, each with its source
FigureValue, source and document
Price to earnings17.44x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
P/E on trailing twelve months33.72x ComputedClose of Oct 15, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings
Price to book1.57x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Price to sales1.75x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Enterprise value to EBIT13.16x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Enterprise value to EBITDA9.41x ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Price to earnings over growth
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Diluted earnings per share2.14 USD FiledFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Graham number33.79 USD ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017

We publish no fair value or price target of our own. Value AMRZ on your own assumptions in the DCF workbench, starting from the filed figures.

Its own record, and companies like it

Valuation

What the market charges for Amrize Ltd today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.

Amrize Ltd: valuation
Share price37.32 USD
Market capitalisation20.41B USD
Enterprise value to EBITDA9.41x
Graham number33.79 USD
Diluted earnings per share, FY20252.14 USD

Price to earnings on trailing twelve months, a different basis from the fiscal-year P/E above, since Oct 29, 2025: low 13.13x, median 18.80x, high 46.57x, latest 33.72x. 240 trading days with a meaningful ratio. Each close over the trailing twelve months of earnings as known that day: a quarter counts from the day it was filed.

Companies like Amrize Ltd

  1. James Hardie Industries plc (JHX)Market cap 15.04B USD
  2. CRH plc (CRH)Market cap 54.77B USD
  3. CEMEX, S.A.B. de C.V. (CX)Market cap 14.60B USD
  4. Vulcan Materials Company (VMC)Market cap 32.71B USD
  5. Martin Marietta Materials, Inc. (MLM)Market cap 29.51B USD

Same industry (Construction Materials) and size band (Large, 10B to 200B), nearest in market value, net margin and current ratio. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.

6 of 10

Cash generation

Whether profit arrives as cash, and what is paid back to shareholders.

SEC filingComputed

Amrize Ltd: cash generation and what is paid out, each with its source
FigureValue, source and document
Free cash flow yield6.9% ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Free cash flow1.42B USD ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Free cash flow margin12.0% ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Dividend yield
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Payout ratio
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
FY2021 Free cash flow: 1.10B USDFY2021 Net income: 841.0M USDFY2022 Free cash flow: 1.50B USDFY2022 Net income: 1.11B USDFY2023 Free cash flow: 1.41B USDFY2023 Net income: 956.0M USDFY2024 Free cash flow: 1.64B USDFY2024 Net income: 1.27B USDFY2025 Free cash flow: 1.42B USDFY2025 Net income: 1.19B USD
Free cash flow Net incomeProfit that arrives as cash stands level with net income; a gap year after year is worth reading about.

7 of 10

Filings

Every figure, the year it is for and the document it was read from.

SEC filingMarket data

The filed figures

Computed from the accounts this company filed with the SEC and, in a ratio with a price in it, the last close, dated on this page. Every filed figure below carries the fiscal year and the filing date its accounts were read from, and every blank carries the reason it is blank. Nothing here is a view on this company.

Amrize Ltd: the eight ratios, with the fiscal year and filing date behind each.
FigureValueYearAs of
17.44xFY2025Oct 15, 2026
1.57xFY2025Oct 15, 2026
13.16xFY2025Oct 15, 2026
6.9%FY2025Oct 15, 2026
8.5%FY2025Feb 18, 2026
n/aFY2025Oct 15, 2026
n/a The filed cash flow statement reports no dividend paid at all. That is not the same as a filed zero, and we will not read it as one.
0.48FY2025Feb 18, 2026
1.60FY2025Feb 18, 2026
1.75xFY2025Oct 15, 2026
n/aFY2025Oct 15, 2026
n/a This figure compares a year against the one before it, and we hold one filed year for this company.
2.01FY2025Oct 15, 2026
-3.46FY2025Feb 18, 2026
3/9FY2025Feb 18, 2026

The figures are computed from the accounts for fiscal 2025, the newest full year on file. 3 filed fiscal years on record, FY2023 to FY2025, from SEC EDGAR. Prices as of Oct 15, 2026. Ratios recomputed Oct 15, 2026. Two facts, because a recompute is not a fresh quote.

The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.

Ten years of filed figures, year by year

Ten years of filed figures

5 fiscal years, FY2021 to FY2025. 3 read from the annual reports Amrize Ltd filed with the SEC, each naming its filing; the rest from statements that name none, which are market data. Amounts in USD, as reported.

Amrize Ltd: revenue, earnings, free cash flow and returns, by fiscal year, with the filing each year was read from
YearRevenueOperating incomeNet incomeEPS, dilutedFree cash flowOperating marginReturn on equityFiling
FY202511.81B1.91B1.19B2.141.42B16.1%9.0%10-K, Feb 18, 20260002035989-26-000017
FY202411.70B2.19B1.27B2.301.64B18.8%12.8%10-K, Feb 18, 20260002035989-26-000017
FY202311.68B1.89B956.0M1.731.41B16.2%n/a10-K, Feb 18, 20260002035989-26-000017
FY202210.73B1.70B1.11B2.001.50B15.8%13.5%Market data, supplied Oct 15, 2026accession n/a
FY20218.13B1.29B841.0M1.521.10B15.8%n/aMarket data, supplied Oct 15, 2026accession n/a
  • Revenue, compound annual growth FY2021 to FY2025: 9.8%
  • Earnings, compound annual growth FY2021 to FY2025: 9.0%
  • Earnings per share, compound annual growth FY2021 to FY2025: 8.9%
  • Free cash flow, compound annual growth FY2021 to FY2025: 6.6%

Every figure in this section is a line of a filed annual statement or a ratio of two of them. Nothing here is estimated or smoothed. Earnings per share filed before a share split are put on today's share count, and say so. Nothing here is a verdict on the company.

8 of 10

Risks and guardrails

The accounting screens, the published tests, and the lines you can set to be told.

ComputedCompany statement

Amrize Ltd: accounting screens and published tests, each with its source
FigureValue, source and document
Beneish M-score-3.46 ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Piotroski F-score3/9 ComputedFY2025 10-K, filed Feb 18, 2026, 0002035989-26-000017
Named tests met0 of 30 Computed
Beta
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026

The named tests

Of 30 tests value investors published: 0 met, 28 not met, 2 we could not complete. Counts, never a score: a single figure would have to decide that meeting one investor’s criteria and meeting another’s are worth the same.

Which tests, by name(all 30)
Meets
None of the named tests.
Does not
Defensive investor (Benjamin Graham); Deep value; Large cap, low P/E; Earnings yield and ROIC (Joel Greenblatt); High F-score, low P/B (Joseph Piotroski); Three forensic scores; Low PEG, low debt (Peter Lynch); High returns and growth; Gross margin, turnover (Robert Novy-Marx); EV/EBITDA and coverage; Dividends and buybacks; Low beta, profitable; ROIC at or above WACC; Near the 52-week low; Z-score and coverage (Edward Altman); Two thirds of NCAV (Benjamin Graham); P/E times P/B (Benjamin Graham); High returns, low debt; Owner earnings yield; High return on tangibles; Low P/S, rising earnings (James O'Shaughnessy); Book or below, low debt (Walter Schloss); Tangible book or below; Cash-flow yield and ROIC; Clean books, high ROIC; Cheapest quarter on P/E (David Dreman); Cheapest quarter on P/B (David Dreman); Low P/E, growth, yield (John Neff)
Not measured
High yield, low payout; Cash-covered dividend. A test with a figure we could not read is incomplete, never met and never failed.
Figures we could not read(9)
  • Positive Earnings Streak: We hold 5 profitable filed years in a row; the test needs 10.
  • PEG Ratio: We do not hold this figure for this company, so there is nothing to show.
  • Eps Growth 5Y: We do not hold this figure for this company, so there is nothing to show.
  • Rev Growth 5Y: We do not hold this figure for this company, so there is nothing to show.
  • Dividend Yield: We do not hold this figure for this company, so there is nothing to show.
  • Payout Ratio: We do not hold this figure for this company, so there is nothing to show.
  • Beta: We do not hold this figure for this company, so there is nothing to show.
  • Dividend Coverage Ratio: We do not hold this figure for this company, so there is nothing to show.
  • Dividend Streak: We do not hold this figure for this company, so there is nothing to show.

9 of 10

Declared positions

Whether anybody here owns this company.

Positions declared by Javier Sanz Alvarez: no holding in any company shown here, as of October 3, 2026.

10 of 10

Next step

What to do with what you have read.

A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.

More on this company

What this cannot tell you

  • 9 figures could not be read on this company, among them Positive Earnings Streak, PEG Ratio, Eps Growth 5Y. Each blank in the table above names the rest, with its reason. 2 named tests come back incomplete because of them, which is neither met nor missed.
  • We hold 3 filed fiscal years rather than 10, so the run above is shorter than a full decade and is counted as what it is.

And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.

Running this once is arithmetic on public documents and you are welcome to it. Writing down why you own each company, in your own words and with the numbers that have to stay true for it to hold, and then having those numbers re-checked every night against the newest filed accounts, and against the latest close where a rule watches a price, is Professional, the plan a new account starts on for 30 days, one trial per person. It writes to you the day one breaks, and stays quiet when nothing does. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published.

Monitor my portfolioHow this is computed

No card. 30 free days, and nothing is charged unless you choose a plan.

Analyze your own portfolio

ValueScreener · valuescreener.ai · Computed from accounts filed with the SEC by this company, read from EDGAR, and from dated closing prices. On this page a filed figure opens into its formula, its inputs and the statement, fiscal year and filing date it was read from, and a price into the day of its close. A figure that cannot show that trail says so.

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Margin Notes

Once a week, what changed in the filings of US-listed companies, why it can matter to a thesis, and what deserves a closer review. Grounded in filings, not market noise.

Site map

Apps

  • Android app coming soon
  • iPhone app coming soon
ValueScreener

Discover companies, research each one to its filings, track what matters, and take your work into your own spreadsheet.

ValueScreener is a trading name of Oliva Real Estate Technologies LLC, a Delaware limited liability company. Legal notices: legal@valuescreener.ai. © 2026 Oliva Real Estate Technologies LLC. All rights reserved.

Risk disclaimer. This service is provided for research and education only. Nothing on it is investment advice, a recommendation, or an offer to buy or sell any security. Capital is at risk, and past performance does not indicate future results. Figures come from filed accounts and may be incomplete, delayed or later restated, so verify a number against the filing before you act on it.

With your permission, Google Analytics, Microsoft Clarity and HubSpot set cookies to measure how this site and the product are used, including recordings of sessions. Nothing is set unless you allow it. Privacy policy